67
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Decreased T Cell Levels in Critically Ill Coronavirus Patients: Single-Center, Prospective and Observational Study

, , , , , , , , ORCID Icon & show all
Pages 1331-1340 | Published online: 09 Apr 2021

References

  • Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017
  • Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12:135. doi:10.3390/v12020135
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497–506. doi:10.1016/S0140-6736(20)30183-5
  • Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010;238:247–262. doi:10.1111/j.1600-065X.2010.00951.x
  • Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235–238. doi:10.1038/nature04753
  • Durant L, Watford WT, Ramos HL, et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity. 2010;32:605–615. doi:10.1016/j.immuni.2010.05.003
  • Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967–974. doi:10.1038/ni1488
  • Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–2629. doi:10.1172/JCI137244
  • Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi:10.3389/fimmu.2020.00827
  • Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi:10.1056/NEJMoa2001316
  • Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (London, England). 2020;395:514–523. doi:10.1016/S0140-6736(20)30154-9
  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020;395:507–513. doi:10.1016/S0140-6736(20)30211-7
  • Arruvito L, Payaslian F, Baz P, et al. Identification and clinical relevance of naturally occurring human CD8+HLA-DR+ regulatory T cells. J Immunol. 2014;193:4469–4476. doi:10.4049/jimmunol.1401490
  • Moon C. Fighting COVID-19 exhausts T cells. Nat Rev Immunol. 2020;20:277. doi:10.1038/s41577-020-0304-7
  • Benlyamani I, Venet F, Coudereau R, Gossez M, Monneret G. Monocyte HLA-DR measurement by flow cytometry in COVID-19 patients: an interim review. Cytometry A. 2020;97(12):1217–1221. doi:10.1002/cyto.a.24249
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422. doi:10.1016/S2213-2600(20)30076-X
  • Younan P, Iampietro M, Nishida A, et al. Ebola virus binding to Tim-1 on T lymphocytes induces a cytokine storm. MBio. 2017;8. doi:10.1128/mBio.00845-17
  • La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol. 2007;85:85–92. doi:10.1038/sj.icb.7100026
  • Xu Y, Chen Y, Tang X. Guidelines for the diagnosis and treatment of COVID-19 by the National Health Commission (Trial Version 7). Global Health Med. 2020;2(2):66–72. doi:10.35772/ghm.2020.01015
  • Zhang C, Li F, Li J, Xu Y, Wang L, Zhang Y. Docetaxel down-regulates PD-1 expression via STAT3 in T lymphocytes. Clin Lung Cancer. 2018;19:e675–e683. doi:10.1016/j.cllc.2018.04.010
  • Xing YN, Zhang JY, Xu HM. The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells. Onco Targets Ther. 2016;9:3939–3949. doi:10.2147/OTT.S105245
  • Wei T, Zhang J, Qin Y, et al. Increased expression of immunosuppressive molecules on intratumoral and circulating regulatory T cells in non-small-cell lung cancer patients. Am J Cancer Res. 2015;5:2190–2201.
  • Papadopoulos P, Pistiki A, Theodorakopoulou M, et al. Immunoparalysis: clinical and immunological associations in SIRS and severe sepsis patients. Cytokine. 2017;92:83–92. doi:10.1016/j.cyto.2017.01.012
  • Yang HM, Yu Y, Chai JK, Hu S, Sheng ZY, Yao YM. Low HLA-DR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro. Burns. 2008;34:1158–1162. doi:10.1016/j.burns.2008.01.026
  • Vester H, Dargatz P, Huber-Wagner S, Biberthaler P, van Griensven M. HLA-DR expression on monocytes is decreased in polytraumatized patients. Eur J Med Res. 2015;20:84. doi:10.1186/s40001-015-0180-y